The DOI matches its Crossref record; 257 of the 257 references it cites were found in a registry or an index.
The multifaceted role of reactive oxygen species in tumorigenesis
Open accessAbstract
Redox homeostasis is an essential requirement of the biological systems for performing various normal cellular functions including cellular growth, differentiation, senescence, survival and aging in humans. The changes in the basal levels of reactive oxygen species (ROS) are detrimental to cells and often lead to several disease conditions including cardiovascular, neurological, diabetes and cancer. During the last two decades, substantial research has been done which clearly suggests that ROS are essential for the initiation, progression, angiogenesis as well as metastasis of cancer in several ways. During the last two decades, the potential of dysregulated ROS to enhance tumor formation through the activation of various oncogenic signaling pathways, DNA mutations, immune escape, tumor microenvironment, metastasis, angiogenesis and extension of telomere has been discovered. At present, surgery followed by chemotherapy and/or radiotherapy is the major therapeutic modality for treating patients with either early or advanced stages of cancer. However, the majority of patients relapse or did not respond to initial treatment. One of the reasons for recurrence/relapse is the altered levels of ROS in tumor cells as well as in cancer-initiating stem cells. One of the critical issues is targeting the intracellular/extracellular ROS for significant antitumor response and relapse-free survival. Indeed, a large number of FDA-approved anticancer drugs are efficient to eliminate cancer cells and drug resistance by increasing ROS production. Thus, the modulation of oxidative stress response might represent a potential approach to eradicate cancer in combination with FDA-approved chemotherapies, radiotherapies as well as immunotherapies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“ROS play an essential role in carcinogenesis, affecting multiple biological processes, including genomic instability, cell growth, angiogenesis, inflammation, metabolic reprogramming, metastatization, and resistance to apoptosis [77].”
From Chronic Inflammation, Oxidative Stress and Metabolic Plasticity: Three Players Driving the Pro-Tumorigenic Microenvironment in Malignant Mesothelioma (2023) · cites this paper as [77]
In the citing paper
“Elevated levels of intracellular ROS are known to be one of the reasons for genomic instability and, hence, carcinogenesis [29].”
From 20-Hydroxyecdysone Confers Antioxidant and Antineoplastic Properties in Human Non-Small Cell Lung Cancer Cells (2023) · cites this paper as [29]
In the citing paper
“ROS are known to play a multifaced, opposing role in cancer, by favoring cancer onset at low doses on the one hand, and killing tumors at high doses on the other hand [29,55].”
From 20-Hydroxyecdysone Confers Antioxidant and Antineoplastic Properties in Human Non-Small Cell Lung Cancer Cells (2023) · cites this paper as [29]
Citations
Cites
2 retracted
Garg, M., Kanojia, D., Mayakonda, A., Ganesan, T. S., Sadhanandhan, B., Suresh, S., Sneha, S., Nagare, R. P., SAID, J. W., Doan, N., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-10325-x · Cited by 48
Self-citationRetractedKanojia, D., Garg, M., Martinez, J., Anand, M. T., Luty, S. B., Doan, N., SAID, J. W., Forscher, C. A., Tyner, J. W., & Koeffler, H. P. (2017) · Journal of Hematology & Oncology · doi:10.1186/s13045-017-0540-x · Cited by 30
Self-citationRetractedBray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Dixon, S. J., Lemberg, K. M., Lamprecht, M. R., Skouta, R., Zaitsev, E. M., Gleason, C. E., Patel, D. N., Bauer, A. J., Cantley, A. M., Yang, W. S., et al. (2012) · Cell · doi:10.1016/j.cell.2012.03.042 · Cited by 18,691
Regulation of Ferroptotic Cancer Cell Death by GPX4
Yang, W. S., SriRamaratnam, R., Welsch, M. E., Shimada, K., Skouta, R., Viswanathan, V. S., Cheah, J. H., Clemons, P. A., Shamji, A. F., Clish, C. B., et al. (2014) · Cell · doi:10.1016/j.cell.2013.12.010 · Cited by 7,713
ROS function in redox signaling and oxidative stress
Schieber, M., & Chandel, N. S. (2014) · Current Biology · doi:10.1016/j.cub.2014.03.034 · Cited by 6,931
5-Fluorouracil: mechanisms of action and clinical strategies
Longley, D. B., Harkin, D. P., & Johnston, P. G. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1074 · Cited by 5,332
Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients
Gopalakrishnan, V., Spencer, C. N., Nezi, L., Reuben, A., Andrews, M. C., Karpinets, T. V., Prieto, P. A., Vicente, D., Hoffman, K., Wei, S. C., et al. (2018) · Science · doi:10.1126/science.aan4236 · Cited by 4,812
Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice
Friedmann Angeli, J. P., Schneider, M., Proneth, B., Tyurina, Y. Y., Tyurin, V. A., Hammond, V. J., Herbach, N., Aichler, M., Walch, A., Eggenhofer, E., et al. (2014) · Nature Cell Biology · doi:10.1038/ncb3064 · Cited by 3,732
Ferroptosis: process and function
Xie, Y., Hou, W., Song, X., Yu, Y., Huang, J., Sun, X., Kang, R., & Tang, D. (2016) · Cell Death & Differentiation · doi:10.1038/cdd.2015.158 · Cited by 3,727
Cited by
Sorted by citations
Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy
Gao, W., Wang, Y., Zhou, Y., Wang, X., & Yu, Y. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01046-3 · Cited by 1,078
“It has been demonstrated by Lin X et al. that ROS may stimulate an invasive phenotype in TAMs derived from melanoma through the secretion of TNFα.343 Researchers have found several mitochondrial genes highly expressed in TAMs derived from melanomas, indicating ROS is the major cause of oxidative stress within TAMs.334…”
BackgroundInfluentialEmerging role of exosomes in cancer progression and tumor microenvironment remodeling
Paskeh, M. D. A., Entezari, M., Mirzaei, S., Zabolian, A., Saleki, H., Naghdi, M. J., Sabet, S., Khoshbakht, M. A., Hashemi, M., Hushmandi, K., et al. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01305-4 · Cited by 582
Self-citationAfzal, S., Manap, A. S. A., Attiq, A., Albokhadaim, I. F., Kandeel, M. K., & Alhojaily, S. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1269581 · Cited by 482
Weaver, K., & Skouta, R. (2022) · Biomedicines · doi:10.3390/biomedicines10040891 · Cited by 288
“Recent studies showed that oxidative injuries were involved in neurodegeneration such as Alzheimer’s and Parkinson’s disease [53,54], cancer [55,56], diabetes [57], and cardiovascular diseases [58,59].”
BackgroundGuan, Z., Chen, J., Li, X., & Dong, N. (2020) · Bioscience Reports · doi:10.1042/bsr20201807 · Cited by 235
Ferroptosis as a potential target for cancer therapy
Chen, Z., Wang, W., Razak, S. R. A., Han, T., Ahmad, N. H., & Li, X. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05930-w · Cited by 212
Rauf, A., Khalil, A. A., Awadallah, S. M., Khan, S. A., Abu‐Izneid, T., Kamran, M., Hemeg, H. A., Mubarak, M. S., Khalid, A., & Wilairatana, P. (2023) · Food Science & Nutrition · doi:10.1002/fsn3.3784 · Cited by 220
“…instability, drug resistance, apoptotic resistance, and alterations in cellular metabolism in various cancer cells (de la Vega Rojo et al., 2018; Kerins & Ooi, 2018) Depleted NRF2 showed reduced tumor growth through enhancement of oxidative stress-dependent cellular death (Kirtonia et al., 2020 ).”
BackgroundInfluentialDiosgenin: An Updated Pharmacological Review and Therapeutic Perspectives
Semwal, P., Painuli, S., Abu-Izneid, T., Rauf, A., Sharma, A., Daştan, S. D., Kumar, M., Alshehri, M. M., Taheri, Y., Das, R., et al. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/1035441 · Cited by 195
“The oxidative stress caused by the reactive oxygen stress leads to various ailments such as neurological disorders, cardiovascular diseases, and cancer [58 – 60].”
Long non-coding RNAs in the doxorubicin resistance of cancer cells
Ashrafizaveh, S., Ashrafizadeh, M., Zarrabi, A., Husmandi, K., Zabolian, A., Shahinozzaman, M., Aref, A. R., Hamblin, M. R., Nabavi, N., Crea, F., et al. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.03.018 · Cited by 191
CircBCAR3 accelerates esophageal cancer tumorigenesis and metastasis via sponging miR-27a-3p
Xi, Y., Shen, Y., Wu, D., Zhang, J., Lin, C., Wang, L., Yu, C., Yu, B., & Shen, W. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01615-8 · Cited by 165
“Since cancer and normal cells show physiological differences in iron and lipid metabolism along with aberrant ROS production [22, 23], cancer cells may be more susceptible to modulation in ferroptosis than normal cells.”
BackgroundReactive Oxygen Species Bridge the Gap between Chronic Inflammation and Tumor Development
Yu, W., Tu, Y., Long, Z., Liu, J., Kong, D., Peng, J., Wu, H., Zheng, G., Zhao, J., Chen, Y., et al. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/2606928 · Cited by 161
“ROS reportedly trigger EMT by activating various pathways, including E-cadherin, N-cadherin, vimentin, and Snail [209].”
Reactive Oxygen Species and Antitumor Immunity—From Surveillance to Evasion
Kotsafti, A., Scarpa, M., Castagliuolo, I., & Scarpa, M. (2020) · Cancers · doi:10.3390/cancers12071748 · Cited by 157
“As previously described, low levels of ROS are necessary for proper T cell activation, proliferation and differentiation, while high ROS have been noticed as one of the major factors for immunosuppression and inhibition for T cell activation and proliferation inside the TME [53,104].”
BackgroundAshrafizadeh, M., Zarrabi, A., Hashemi, F., Moghadam, E. R., Hashemi, F., Entezari, M., Hushmandi, K., Mohammadinejad, R., & Najafi, M. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117984 · Cited by 151
Zhao, Z., Dong, S., Liu, Y., Wang, J., Ba, L., Zhang, C., Cao, X., Wu, C., & Yang, P. (2022) · ACS Nano · doi:10.1021/acsnano.2c06646 · Cited by 151
Mirzaei, S., Hushmandi, K., Zabolian, A., Saleki, H., Torabi, S. M., Ranjbar, A., SeyedSaleh, S., Sharifzadeh, S. O., Khan, H. Z., Ashrafizadeh, M., et al. (2021) · Molecules · doi:10.3390/molecules26082382 · Cited by 150
Lu, Y., Pan, Q., Gao, W., Pu, Y., Luo, K., He, B., & Gu, Z. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2021.121335 · Cited by 149
Targeting autophagy in prostate cancer: preclinical and clinical evidence for therapeutic response
Ashrafizadeh, M., Paskeh, M. D. A., Mirzaei, S., Gholami, M. H., Zarrabi, A., Hashemi, F., Hushmandi, K., Hashemi, M., Nabavi, N., Crea, F., et al. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02293-6 · Cited by 150
Garg, M., Shanmugam, M. K., Bhardwaj, V., Goel, A., Gupta, R., Sharma, A., Baligar, P., Kumar, A. P., Goh, B. C., Wang, L., et al. (2020) · Medicinal Research Reviews · doi:10.1002/med.21761 · Cited by 143
“prostrate carcinoma.(203,204) Robust activation of STAT3 has been associated with radio and chemoresistance because of an increase in CD133 CSCs in thyroid cancer.”
BackgroundSelf-citationPaskeh, M. D. A., Mirzaei, S., Ashrafizadeh, M., Zarrabi, A., & Sethi, G. (2021) · Journal of Hepatocellular Carcinoma · doi:10.2147/jhc.s336858 · Cited by 140
“It is obvious that enhanced ROS generation can reduce viability of HCC cells via mediating apoptosis.(99,100) A recent experiment has shed more light on the role of ROS in HCC.”
BackgroundSelf-citationFerroptosis: An emerging approach for targeting cancer stem cells and drug resistance
Elgendy, S. M., Alyammahi, S. K., Alhamad, D. W., Abdin, S. M., & Omar, H. A. (2020) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2020.103095 · Cited by 134
Zhang, J., Yao, M., Xia, S., Zeng, F., & Liu, Q. (2025) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-024-00682-7 · Cited by 145
Celastrol in cancer therapy: Recent developments, challenges and prospects
Lim, H. Y., Ong, P. S., Wang, L., Goel, A., Ding, L., Li-Ann Wong, A., Ho, P. C.-L., Sethi, G., Xiang, X., & Goh, B. C. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.08.030 · Cited by 118
Self-citationMirzaei, S., Zarrabi, A., Hashemi, F., Zabolian, A., Saleki, H., Azami, N., Hamzehlou, S., Farahani, M. V., Hushmandi, K., Ashrafizadeh, M., et al. (2021) · Antioxidants · doi:10.3390/antiox10030349 · Cited by 118
Rationalizing the therapeutic potential of apigenin against cancer
Ahmed, S. A., Parama, D., Daimari, E., Girisa, S., Banik, K., Harsha, C., Dutta, U., & Kunnumakkara, A. B. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118814 · Cited by 113
Yang, Y., Liu, L., Tian, Y., Gu, M., Wang, Y., Ashrafizadeh, M., Aref, A. R., Cañadas, I., Klionsky, D. J., Goel, A., et al. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.216659 · Cited by 109
Cao, Y., Wang, J., Tian, H., & Fu, G. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01621-y · Cited by 108
“Antitumor drugs anthracyclines and topoisomerase inhibitors such as doxorubicin, adriamycin, daunorubicin, and epirubicin can block DNA synthesis, topoisomerase II activity and complex I/II and increase mitochondrial ROS production to kill tumor cells [14, 15].”
In Vitro Cytotoxic Activity of African Plants: A Review
Canga, I. L. V., Vita, P., Oliveira, A. I., Castro, M. A., & Pinho, C. (2022) · Molecules · doi:10.3390/molecules27154989 · Cited by 108
“It is also known that reactive oxygen species (ROS) are involved in tumor formation through the activation of various oncogenic signaling pathways, DNA mutations, immune escape, the tumor microenvironment, metastasis, and angiogenesis [1].”
BackgroundRegulation of CD8+ T cells by lipid metabolism in cancer progression
Tang, Y., Chen, Z., Zuo, Q., & Kang, Y. (2024) · Cellular and Molecular Immunology · doi:10.1038/s41423-024-01224-z · Cited by 114
“High ROS levels are major factors that inhibit T-cell activation and proliferation in the tumor microenvironment [114].”
BackgroundНеганова, М. Е., Liu, J., Aleksandrova, Y. R., Klochkov, S. G., & Fan, R. (2021) · Cancers · doi:10.3390/cancers13236062 · Cited by 110
“Free radicals that cause genetic mutations can contribute to the initiation of the processes of normal cell transformation into a tumor cell, while simultaneously playing an essential role in all carcinogenesis stages [23,24].”
BackgroundRecent advances in waste-recycled nanomaterials for biomedical applications: Waste-to-wealth
Elkodous, M. A., El‐Husseiny, H. M., El-Sayyad, G. S., Hashem, A. H., Doghish, A. S., Elfadil, D., Radwan, Y., El-Zeiny, H. M., Bedair, H., Ikhdair, O. A., et al. (2021) · Nanotechnology Reviews · doi:10.1515/ntrev-2021-0099 · Cited by 106
Zhang, H., Wang, M., He, Y., Deng, T., Liu, R., Wang, W., Zhu, K., Bai, M., Ning, T., Yang, H., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04406-z · Cited by 106
“Since aberrant lipid and iron metabolism, along with ROS production, are some of the physiological differences between cancer and normal cells [13, 14], and play essential roles in regulating ferroptosis, cancer cells could be more susceptible to modulation in this death pathway compared to normal cells [15].”
BackgroundReactive Oxygen Species: A Crosslink between Plant and Human Eukaryotic Cell Systems
Guo, W., Xing, Y., Luo, X., Li, F., Ren, M., & Liang, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713052 · Cited by 114
How to improve photodynamic therapy-induced antitumor immunity for cancer treatment?
Zhang, M., Zhao, Y., Ma, H., Sun, Y., & Cao, J. (2022) · Theranostics · doi:10.7150/thno.72465 · Cited by 102
“Flow cytometry detection of CD40 and CD86 on CD11c+ DCs showed that after FS@PMPt treatment, CD8+ T cell infiltration was increased, while the proportion of Tregs was decreased.”
BackgroundInfluentialNanomedicine Strategies in Conquering and Utilizing the Cancer Hypoxia Environment
Pan, Y., Liu, L., Mou, X., & Cai, Y. (2023) · ACS Nano · doi:10.1021/acsnano.3c07763 · Cited by 98
Trombetti, S., Cesaro, E., Catapano, R., Sessa, R., Bianco, A. L., Izzo, P., & Grosso, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052470 · Cited by 91
“The most abundant non-enzymatic ROS scavenger, glutathione (GSH) and its related enzymatic activities including glutathione reductase (GR), glutathione peroxidase (GPx) and glutathione S-transferase (GST) participate in H2O2 detoxification (Figure 2) and play a critical role in different cellular processes such as pro…”
BackgroundGraphene oxide nanoarchitectures in cancer biology: Nano-modulators of autophagy and apoptosis
Taheriazam, A., Abad, G. G. Y., Hajimazdarany, S., Imani, M. H., Ziaolhagh, S., Zandieh, M. A., Bayanzadeh, S. D., Mirzaei, S., Hamblin, M. R., Entezari, M., et al. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.01.028 · Cited by 93
Tuli, H. S., Kaur, J., Vashishth, K., Sak, K., Sharma, U., Choudhary, R., Behl, T., Singh, T., Sharma, S., Saini, A. K., et al. (2022) · Archives of Toxicology · doi:10.1007/s00204-022-03421-z · Cited by 91
“On the other hand, it is well known that excessive production of ROS and ROS-induced oxidative stress can play a substantial role in tumorigenesis, causing damages to vital biomolecules, such as DNA, proteins and lipids (Srinivas et al. 2019; Kirtonia et al. 2020; Wang et al. 2020; Ulker et al. 2022).”
BackgroundSelf-citationThe interplay between autophagy and apoptosis: its implication in lung cancer and therapeutics
Biswas, U., Roy, R., Ghosh, S., & Chakrabarti, G. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.216662 · Cited by 93
Ashrafizadeh, M., Ang, H. L., Moghadam, E. R., Mohammadi, S., Zarrin, V., Hushmandi, K., Samarghandian, S., Zarrabi, A., Najafi, M., Mohammadinejad, R., et al. (2020) · Biomolecules · doi:10.3390/biom10071040 · Cited by 87
“Generally, it is believed that enhancing level of oxidative stress can lead to a reduction in the viability of cancer cells by predisposing them into apoptosis [135,136].”
BackgroundRole of the Synergistic Interactions of Environmental Pollutants in the Development of Cancer
Lagunas‐Rangel, F. A., Linnea‐Niemi, J. V., Kudłak, B., Williams, M. J., Jönsson, J., & Schiöth, H. B. (2022) · GeoHealth · doi:10.1029/2021gh000552 · Cited by 98
“During various pathological processes, including cardiovascular, neurological, diabetes, and cancer, ROS levels increase (Kirtonia et al., 2020; Lagunas-Rangel, 2020).”
BackgroundOxidative Stress and Age-Related Tumors
Carlo, E. D., & Sorrentino, C. (2024) · Antioxidants · doi:10.3390/antiox13091109 · Cited by 101
“76].”
BackgroundInfluentialNanomaterial-based regulation of redox metabolism for enhancing cancer therapy
Jia, X., Wang, Y., Qiao, Y., Jiang, X., & Li, J. (2024) · Chemical Society Reviews · doi:10.1039/d4cs00404c · Cited by 87
Ashrafizadeh, M., Saebfar, H., Gholami, M. H., Hushmandi, K., Zabolian, A., Bikarannejad, P., Hashemi, M., Daneshi, S., Mirzaei, S., Sharifi, E., et al. (2022) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2022.2041598 · Cited by 86
Targeting oxidative stress-mediated regulated cell death as a vulnerability in cancer
Chen, D., Guo, Z., Yao, L., Sun, Y., Dian, Y., Zhao, D., Ke, Y., Zeng, F., Zhang, C., Deng, G., et al. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103686 · Cited by 91
“…myeloid-derived suppressor cells (MDSCs), regulatory T cells (Tregs), and tumor-associated macrophages (TAMs), and collectively leading to the suppression of NK cells and CTLs through direct ROS-induced damage and the release of immunosuppressive cytokines such as IL-10 and TGF-β [116,117].”
Oshi, M., Gandhi, S., Yan, L., Tokumaru, Y., Wu, R., Yamada, A., Matsuyama, R., Endo, I., & Takabe, K. (2022) · Breast Cancer Research and Treatment · doi:10.1007/s10549-022-06633-0 · Cited by 88
“Proper T cell activation, proliferation, and differentiation depend on low levels of ROS [59, 60].”
BackgroundAshrafizadeh, M., Mirzaei, S., Hushmandi, K., Rahmanian, V., Zabolian, A., Raei, M., Farahani, M. V., Goharrizi, M. A. S. B., Khan, H. Z., Zarrabi, A., et al. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119649 · Cited by 80
Role of Telomeres and Telomeric Proteins in Human Malignancies and Their Therapeutic Potential
Fernandes, S. G., Dsouza, R., Pandya, G., Kirtonia, A., Tergaonkar, V., Lee, S. Y., Garg, M., & Khattar, E. (2020) · Cancers · doi:10.3390/cancers12071901 · Cited by 80
Self-citationThe gut microbiota metabolite urolithin A inhibits NF-κB activation in LPS stimulated BMDMs
Abdelazeem, K. N. M., Kalo, M. Z., Beer‐Hammer, S., & Lang, F. J. W. (2021) · Scientific Reports · doi:10.1038/s41598-021-86514-6 · Cited by 81
FUNDC2 promotes liver tumorigenesis by inhibiting MFN1-mediated mitochondrial fusion
Li, S., Han, S., Zhang, Q., Zhu, Y., Zhang, H., Wang, J., Zhao, Y., Zhao, J., Su, L., Li, L., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-31187-6 · Cited by 79
Anti-Inflammatory and Anticancer Properties of Birch Bark-Derived Betulin: Recent Developments
Tuli, H. S., Sak, K., Gupta, D., Kaur, G., Aggarwal, D., Parashar, N. C., Choudhary, R., Yerer, M. B., Kaur, J., Kumar, M., et al. (2021) · Plants · doi:10.3390/plants10122663 · Cited by 81
Self-citationMitochondria: The metabolic switch of cellular oncogenic transformation
Tan, Y. Q., Zhang, X., Zhang, S., Zhu, T., Garg, M., Lobie, P. E., & Pandey, V. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188534 · Cited by 75
Self-citationThe evolutionary legacy of immune checkpoint inhibitors
Kaushik, I., Ramachandran, S., Zabel, C., Gaikwad, S., & Srivastava, S. K. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.03.020 · Cited by 79
Makvandi, P., Ghomi, M., Ashrafizadeh, M., Tafazoli, A., Agarwal, T., Delfi, M., Akhtari, J., Zare, E. N., Padil, V. V. T., Zarrabi, A., et al. (2020) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2020.116952 · Cited by 75
Resveratrol in breast cancer treatment: from cellular effects to molecular mechanisms of action
Behroozaghdam, M., Dehghani, M., Zabolian, A., Kamali, D., Javanshir, S., Sadi, F. H., Hashemi, M., Tabari, T., Rashidi, M., Mirzaei, S., et al. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04551-4 · Cited by 77
The application of nanoparticles-based ferroptosis, pyroptosis and autophagy in cancer immunotherapy
Deng, W., Shang, H., Tong, Y., Liu, X., Huang, Q., He, Y. T., Wu, J., Ba, X., Chen, Z., Chen, Y., et al. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02297-8 · Cited by 75
“As a key component of ferroptosis, Reactive oxygen species could induce lipid peroxidation that can have significant implications for the modulation of immunity in human malignancies, in addition to its role in oxidative stress [59].”
BackgroundInsights into the Role of Oxidative Stress in Ovarian Cancer
Ding, D., Xie, L., Shen, Y., Li, J., Guo, Y., Fu, Y., Liu, F.-Y., & Han, F. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/8388258 · Cited by 73
Yu, L., Huang, K., Liao, Y., Wang, L., Sethi, G., & Ma, Z. (2024) · Cell Proliferation · doi:10.1111/cpr.13644 · Cited by 71
“55,56 Emerging evidence has revealed that ferroptosis exerts a critical role in regulating tumour immunity, particularly in PD1 checkpoint blockade therapies.”
BackgroundSelf-citationMicroRNAs as Modulators of Oral Tumorigenesis—A Focused Review
Rishabh, K., Khadilkar, S., Kumar, A., Kalra, I., Kumar, A. P., & Kunnumakkara, A. B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052561 · Cited by 70
The role of SOX family transcription factors in gastric cancer
Abadi, A. J., Zarrabi, A., Hashemi, F., Zabolian, A., Najafi, M., Entezari, M., Hushmandi, K., Aref, A. R., Khan, H. Z., Makvandi, P., et al. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.02.202 · Cited by 70
Cancer depends on fatty acids for ATP production: A possible link between cancer and obesity
Lee, H., Woo, S. M., Jang, H., Kang, M., & Kim, S. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.07.005 · Cited by 71
Sun, C., Han, B., Zhai, Y., Zhao, H., Li, X., Qian, J., Hao, X., Liu, Q., Shen, J., & Kai, G. (2022) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2022.01.015 · Cited by 68
The interplay of oncogenic signaling, oxidative stress and ferroptosis in cancer
Zeng, W., Long, X., Liu, P., & Xie, X. (2023) · International Journal of Cancer · doi:10.1002/ijc.34486 · Cited by 70
“In addition, oxidative stress activates a multitude of signaling pathways to sustain hyperproliferation and cell survival, such as MAPK/ERK, PI3K/Akt and NF-κB pathway.(3,4,37) For example, H2O2 modulates the enzymatic activity of protein tyrosine kinases (PTKs) and protein tyrosine phosphatases (PTPs) by inducing pro…”
BackgroundPTEN: What we know of the function and regulation of this onco-suppressor factor in bladder cancer?
Ashrafizadeh, M., Zarrabi, A., Samarghandian, S., & Najafi, M. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173226 · Cited by 66
Wang, J., Sun, D., Huang, L., Wang, S., & Jin, Y. H. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/8532940 · Cited by 66
“The use of small molecules to increase the production of ROS or/and inhibit the antioxidant defense system is one of the most effective anticancer methods [87].”
BackgroundRadiotherapy-induced remodeling of the tumor microenvironment by stromal cells
Berg, T. J., & Pietras, A. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.02.011 · Cited by 64
Zhao, B., Wu, B. C., Feng, N., Zhang, X., Zhang, X., Wei, Y., & Zhang, W. (2023) · Journal of Hematology & Oncology · doi:10.1186/s13045-023-01426-4 · Cited by 66
“Moreover, MAPK, PI3K, and STAT3 can be regulated by ROS, which promotes cell proliferation and survival, as has been discovered in breast cancer, lung cancer, pancreatic cancer, and other malignant tumors [52].”
BackgroundRecent Perspective of Lactobacillus in Reducing Oxidative Stress to Prevent Disease
Zhao, T., Wang, H., Liu, Z., Liu, Y., DeJi, Li, B., & Huang, X. (2023) · Antioxidants · doi:10.3390/antiox12030769 · Cited by 69
“ASK-1/JNK/p38 signaling cascade induced via the H2O2-mediated oxidation of cysteine residues on TRX, which leads to the dissociation of ASK-1, the subsequent activation of JNK and p38 signaling, and ultimately apoptosis [59,78] (Figure 2).”
BackgroundInfluentialSharma, A. N., Dewangan, H. K., & Upadhyay, P. K. (2024) · Chemistry & Biodiversity · doi:10.1002/cbdv.202301468 · Cited by 65
Menegazzi, M., Masiello, P., & Novelli, M. (2020) · Antioxidants · doi:10.3390/antiox10010018 · Cited by 69
“Additionally, high ROS levels can trigger angiogenesis through stabilization of hypoxia inducing factor (HIF)-1, that drives the expression of hypoxia-responsive genes leading to upregulation of MMP-1/2/9 and favoring tumor cell infiltration in other tissues [62].”
BackgroundThakur, K. K., Kumar, A., Banik, K., Verma, E., Khatoon, E., Harsha, C., Sethi, G., Gupta, S. C., & Kunnumakkara, A. B. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30463 · Cited by 67
“In cancers, the mechanism to regulate apoptosis is deregulated leading to abnormal proliferation of tumor cells in the vicinity (Kirtonia et al., 2020).”
BackgroundSelf-citationA narrative review of the pharmacology of ginsenoside compound K
Liu, T., Zhu, L., & Wang, L. (2022) · Annals of Translational Medicine · doi:10.21037/atm-22-501 · Cited by 63
“In non-small cell lung cancer cells (A549, H1975), CK promoted autophagy to induce cell apoptosis through the AMPK-mTOR and c-Jun N-terminal kinase (JNK) signaling pathways (69).”
Photoelectric Bacteria Enhance the In Situ Production of Tetrodotoxin for Antitumor Therapy
Wang, X., Niu, M., Fan, J., Chen, Q., & Zhang, X. (2021) · Nano Letters · doi:10.1021/acs.nanolett.1c00408 · Cited by 62
Tumor microenvironment responsive nanozymes for multimodal imaging of tumors
Wang, H., Ouyang, W., & Liu, H. (2024) · Nano TransMed · doi:10.1016/j.ntm.2024.100032 · Cited by 62
Oxidative Stress in Breast Cancer: A Biochemical Map of Reactive Oxygen Species Production
Bel’skaya, L. V., & Dyachenko, E. I. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46050282 · Cited by 71
“On the one hand, a certain physiological level of ROS plays an important regulatory role, participating as specific signaling molecules in the regulation of metabolic processes, gene expression, and the functioning of the immune, endocrine and other physiological systems [4].”
BackgroundMetal nanoparticles in cancer: from synthesis and metabolism to cellular interactions
Tuli, H. S., Joshi, R., Kaur, G., Garg, V. K., Sak, K., Varol, M., Kaur, J., Alharbi, S. A., Alahmadi, T. A., Aggarwal, D., et al. (2022) · Journal of nanostructure in chemistry · doi:10.1007/s40097-022-00504-2 · Cited by 63
Self-citationGlutathione Synthesis in Cancer Cells
Kalinina, E. V., & Гаврилюк, Л. А. (2020) · Biochemistry (Moscow) · doi:10.1134/s0006297920080052 · Cited by 61
“In response to the develop ment of oxidative stress, there is a redox dependent increase in expression of the genes of antioxidant enzymes [10, 11].”
BackgroundA comprehensive review of the multifaceted role of the microbiota in human pancreatic carcinoma
Pandya, G., Kirtonia, A., Singh, A. P., Goel, A., Mohan, C. D., Rangappa, K. S., Pandey, A. K., Kapoor, S., Tandon, S., Sethi, G., et al. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.05.027 · Cited by 59
Self-citationWang, P., Zhou, R., Thomas, P. B., Zhao, L., Zhou, R., Mandal, S., Jolly, M. K., Richard, D. J., Rehm, B. H. A., Ostrikov, K., et al. (2021) · Cancers · doi:10.3390/cancers13122889 · Cited by 60
“ROS levels have also been linked to mitochondrial dysfunction in mesenchymal stem cells from Parkinson’s disease [41] and linked to glucose metabolism in the EMT/breast cancer stem cell phenotype [42], as well as being linked to tumor recurrence/relapse [39].”
BackgroundInterplay of dietary antioxidants and gut microbiome in human health: What has been learnt thus far?
Naliyadhara, N., Kumar, A., Gangwar, S. K., Devanarayanan, T. N., Hegde, M., Alqahtani, M. S., Abbas, M. A. E., Sethi, G., & Kunnumakkara, A. B. (2022) · Journal of Functional Foods · doi:10.1016/j.jff.2022.105365 · Cited by 67
Self-citationFullerenes: Historical background, novel biological activities versus possible health risks
Pesado-Gómez, C., Serrano‐García, J. S., Amaya‐Flórez, A., Pesado-Gómez, G., Soto‐Contreras, A., Morales‐Morales, D., & Colorado‐Peralta, R. (2023) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2023.215550 · Cited by 61
Jung, Y. Y., Ha, I. J., Um, J., Sethi, G., & Ahn, K. S. (2021) · Journal of Advanced Research · doi:10.1016/j.jare.2021.03.008 · Cited by 59
Self-citationUpdate on Pharmacological Activities, Security, and Pharmacokinetics of Rhein
Li, G., Chen, J., Zhang, H., Cao, X.-Y., Sun, C., Peng, F., Yin, Y.-P., Lin, Z., Yu, L., Chen, Y., et al. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/4582412 · Cited by 58
“ROS activated NF-κB to support cancer cell survival by increasing the levels of antioxidants to escape cancer cell death [85].”
BackgroundMetabolic dependencies and targets in ovarian cancer
Zhang, Y., Wang, Y., Zhao, G., Oršulić, S., & Matei, D. E. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108413 · Cited by 60
Signaling pathways of oxidative stress response: the potential therapeutic targets in gastric cancer
Liu, Y., Shi, Y., Han, R., Liu, C., Qin, X., Li, P., & Gu, R. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1139589 · Cited by 58
Mandal, S. K., Maji, A. K., Mishra, S. K., Ishfaq, P. M., Devkota, H. P., Sanches-Silva, A. T., & Das, N. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105085 · Cited by 60
An overview of the pharmacological activities of scopoletin against different chronic diseases
Parama, D., Girisa, S., Khatoon, E., Kumar, A., Alqahtani, M. S., Abbas, M. A. E., Sethi, G., & Kunnumakkara, A. B. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106202 · Cited by 54
Self-citationModulation of reactive oxygen species to enhance sonodynamic therapy
Liu, X., Pan, X., Wang, C., & Liu, H. (2022) · Particuology · doi:10.1016/j.partic.2022.08.001 · Cited by 54
Xu, L., Cao, Y., Ya, X., Li, R., & Xu, X. (2023) · Macromolecular Bioscience · doi:10.1002/mabi.202300238 · Cited by 54
Zhou, Z., Gao, Z., Chen, W., Wang, X., Chen, Z., Zheng, Z., Chen, Q., Tan, M., Liu, D., Zhang, Y., et al. (2022) · Acta Biomaterialia · doi:10.1016/j.actbio.2022.08.011 · Cited by 51
Jin, X., You, L., Qiao, J., Han, W., & Pan, H. (2023) · Autophagy · doi:10.1080/15548627.2023.2259214 · Cited by 53
“ROS have been implicated in the development of dysplasia in IBD, and play crucial roles in cancer initiation, progression, angiogenesis, and metastasis through various mechanisms [59,60].”
BackgroundGrasso, G., Colella, F., Forciniti, S., Onesto, V., Iuele, H., Siciliano, A. C., Carnevali, F., Chandra, A., Gigli, G., & del Mercato, L. L. (2023) · Nanoscale Advances · doi:10.1039/d3na00218g · Cited by 52
High-Dose Vitamin C: Preclinical Evidence for Tailoring Treatment in Cancer Patients
Giansanti, M., Karimi, T., Faraoni, I., & Graziani, G. (2021) · Cancers · doi:10.3390/cancers13061428 · Cited by 50
Verma, E., Kumar, A., Daimary, U. D., Parama, D., Girisa, S., Sethi, G., & Kunnumakkara, A. B. (2021) · Journal of Functional Foods · doi:10.1016/j.jff.2021.104660 · Cited by 49
Self-citationProgress on the study of the anticancer effects of artesunate (Review)
Yang, X., Zheng, Y., Liu, L., Huang, J., Wang, F., & Zhang, J. (2021) · Oncology Letters · doi:10.3892/ol.2021.13011 · Cited by 49
“Dysregulation of ROS has been found to promote tumorigenesis through activation of various oncogenic, signaling pathways such as MAPK, PI3K/AKT/mTOR and NF‐κB (18,40), DNA damage (41,42), immune escape, metastasis, angiogenesis and telomere elongation (40).”
BackgroundInfluentialGundacker, C., Audouze, K., Widhalm, R., Granitzer, S., Forsthuber, M., Jornod, F., Wielsøe, M., Long, M., Halldorsson, T. I., Uhl, M., et al. (2022) · Toxics · doi:10.3390/toxics10110684 · Cited by 48
Anticancer therapeutic effect of cerium-based nanoparticles: known and unknown molecular mechanisms
Amaldoss, M. J. N., Mehmood, R., Yang, J., Koshy, P., Kumar, N., Unnikrishnan, A., & Sorrell, C. C. (2022) · Biomaterials Science · doi:10.1039/d2bm00334a · Cited by 51
Sevoflurane Induces Ferroptosis of Glioma Cells Through Activating the ATF4-CHAC1 Pathway
Xu, Y., Zhang, N., Chen, C., Xu, X., Luo, A., Yan, Y., Lu, Y., Liu, J., Ou, X., Tan, Y., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.859621 · Cited by 47
“Then the loss of GPX4 induces the accumulation of peroxides in the membrane which results in aggregation of destructive lipid ROS (30).”
BackgroundYoo, E., Lee, J., Lertpatipanpong, P., Ryu, J., Kim, C., Park, E.-Y., & Baek, S. J. (2020) · BMC Cancer · doi:10.1186/s12885-020-07379-y · Cited by 47
“Antioxidant activity of natural compounds has been shown to be highly related to anticancer effects [23].”
BackgroundCircular RNAs in cell cycle regulation: Mechanisms to clinical significance
Xiao, W., Li, J., Hu, J., Wang, L., Huang, J. R., Sethi, G., & Ma, Z. (2021) · Cell Proliferation · doi:10.1111/cpr.13143 · Cited by 47
Self-citationAkhtar, H., Amara, U., Mahmood, K., Hanif, M., Khalid, M. A., Qadir, S., Peng, Q., Safdar, M., Amjad, M., Saif, M. Z., et al. (2024) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2024.103184 · Cited by 46
Metadata
- Authors
- Kirtonia, A., Sethi, G., & Garg, M.
- Affiliations
- Amity University (IN)
- National University of Singapore (SG)
- Corresponding author
- Sethi, Gautam
- Garg, Manoj
- Venue
- Cellular and Molecular Life Sciences
- Published
- 2020-05-01
- Volume
- 77
- Issue
- 22
- Pages
- 4459-4483
- ISSN
- 1420-682X (ISSN-L)
- 1420-9071
- PMC
- PMC11105050
- OpenAlex
- W3022746266
- Cited by
- 452
- References
- 257
- Citations by year
- 2026: 33 · 2025: 45 · 2024: 90 · 2023: 72 · 2022: 106 · 2021: 80 · 2020: 26
- FWCI
- 6.79
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Cellular and Molecular Life Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Department of Biotechnology , Ministry of Science and Technology
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer and biochemical research
- Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
- Keywords
- reactive oxygen species, carcinogenesis, redox homeostasis, oxidative stress, metastasis, angiogenesis, oncogenic signaling, DNA mutations, tumor microenvironment, cancer stem cells, drug resistance, anticancer agents, immunotherapy, radiotherapy, chemotherapy
- MeSH terms
- Animals, Humans, Neoplasm Recurrence, Local, Neoplasms, Oxidation-Reduction, Signal Transduction, Reactive Oxygen Species, Oxidative Stress, Carcinogenesis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
